{"id":"https://openalex.org/W2897192545","doi":"https://doi.org/10.1093/annonc/mdy271.274","title":"A phase Ib/II study of durvalumab combined with dose-dense EC in neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)","display_name":"A phase Ib/II study of durvalumab combined with dose-dense EC in neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)","publication_year":2018,"publication_date":"2018-10-01","ids":{"openalex":"https://openalex.org/W2897192545","doi":"https://doi.org/10.1093/annonc/mdy271.274","mag":"2897192545"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdy271.274","doi":"https://doi.org/10.1093/annonc/mdy271.274","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy271.274","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1093/annonc/mdy271.274","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019931969","display_name":"Alix Devaux","orcid":"https://orcid.org/0009-0000-0320-1850","observed_orcids":["https://orcid.org/0009-0000-0320-1850"]},"institutions":[{"id":"https://openalex.org/I4210114657","display_name":"de Duve Institute","ror":"https://ror.org/022em3k58","country_code":"BE","type":"facility","lineage":["https://openalex.org/I4210114657"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"A. Devaux","raw_affiliation_strings":["GECE Unit, De Duve Institute, UCL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GECE Unit, De Duve Institute, UCL, Brussels, Belgium","institution_ids":["https://openalex.org/I4210114657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111785329","display_name":"Jean Luc Canon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J.-L. Canon","raw_affiliation_strings":["Oncology, Grand Hopital de Charleroi Site Notre Dame, Charleroi, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Grand Hopital de Charleroi Site Notre Dame, Charleroi, Belgium","institution_ids":["https://openalex.org/I4210152698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031325232","display_name":"Fran\u00e7ois P. Duhoux","orcid":"https://orcid.org/0000-0002-5429-7888","observed_orcids":["https://orcid.org/0000-0002-5429-7888"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"F.P. Duhoux","raw_affiliation_strings":["Medical Oncology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Brussels, Belgium","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007897192","display_name":"P. Delr\u00e9e","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099787","display_name":"Institute of Pathology and Genetics","ror":"https://ror.org/00zam0e96","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210099787"]},{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P. Delr\u00e9e","raw_affiliation_strings":["Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium","institution_ids":["https://openalex.org/I4210099787","https://openalex.org/I4210152698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081256540","display_name":"Christine Galant","orcid":"https://orcid.org/0000-0002-9206-7864","observed_orcids":["https://orcid.org/0000-0002-9206-7864"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"C. Galant","raw_affiliation_strings":["Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082245754","display_name":"Pierre G. Coulie","orcid":"https://orcid.org/0000-0003-2916-2938","observed_orcids":["https://orcid.org/0000-0003-2916-2938"]},"institutions":[{"id":"https://openalex.org/I4210114657","display_name":"de Duve Institute","ror":"https://ror.org/022em3k58","country_code":"BE","type":"facility","lineage":["https://openalex.org/I4210114657"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P.G. Coulie","raw_affiliation_strings":["GECE Unit, De Duve Institute, UCL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GECE Unit, De Duve Institute, UCL, Brussels, Belgium","institution_ids":["https://openalex.org/I4210114657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054741652","display_name":"Isabelle Bar","orcid":"https://orcid.org/0000-0002-6091-9137","observed_orcids":["https://orcid.org/0000-0002-6091-9137"]},"institutions":[{"id":"https://openalex.org/I4210099787","display_name":"Institute of Pathology and Genetics","ror":"https://ror.org/00zam0e96","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210099787"]},{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"I. Bar","raw_affiliation_strings":["Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium","institution_ids":["https://openalex.org/I4210099787","https://openalex.org/I4210152698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109406932","display_name":"Manuel Constant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099787","display_name":"Institute of Pathology and Genetics","ror":"https://ror.org/00zam0e96","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210099787"]},{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"M. Constant","raw_affiliation_strings":["Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium","institution_ids":["https://openalex.org/I4210099787","https://openalex.org/I4210152698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063977492","display_name":"Sandy Haussy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099787","display_name":"Institute of Pathology and Genetics","ror":"https://ror.org/00zam0e96","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210099787"]},{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"S. Haussy","raw_affiliation_strings":["Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire d\u2019Oncologie Translationnelle, Grand Hopital de Charleroi/Institut de Pathologie et G\u00e9n\u00e9tique, Gosselies, Belgium","institution_ids":["https://openalex.org/I4210099787","https://openalex.org/I4210152698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051415480","display_name":"Orian Bricard","orcid":"https://orcid.org/0000-0003-3976-7228","observed_orcids":["https://orcid.org/0000-0003-3976-7228"]},"institutions":[{"id":"https://openalex.org/I4210114657","display_name":"de Duve Institute","ror":"https://ror.org/022em3k58","country_code":"BE","type":"facility","lineage":["https://openalex.org/I4210114657"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"O. Bricard","raw_affiliation_strings":["GECE Unit, De Duve Institute, UCL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GECE Unit, De Duve Institute, UCL, Brussels, Belgium","institution_ids":["https://openalex.org/I4210114657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072971110","display_name":"K. Missault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114657","display_name":"de Duve Institute","ror":"https://ror.org/022em3k58","country_code":"BE","type":"facility","lineage":["https://openalex.org/I4210114657"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"K. Missault","raw_affiliation_strings":["GECE Unit, De Duve Institute, UCL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GECE Unit, De Duve Institute, UCL, Brussels, Belgium","institution_ids":["https://openalex.org/I4210114657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049749170","display_name":"Martine Berli\u00e8re","orcid":"https://orcid.org/0000-0002-6472-9867","observed_orcids":["https://orcid.org/0000-0002-6472-9867"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"M. Berli\u00e8re","raw_affiliation_strings":["Gynecology, Cliniques Universitaires Saint-Luc, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecology, Cliniques Universitaires Saint-Luc, Brussels, Belgium","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049831015","display_name":"Timour Willems","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"T. Willems","raw_affiliation_strings":["Gynecology, Grand Hopital de Charleroi Site Notre Dame, Charleroi, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecology, Grand Hopital de Charleroi Site Notre Dame, Charleroi, Belgium","institution_ids":["https://openalex.org/I4210152698"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044214543","display_name":"Javier Carrasco","orcid":"https://orcid.org/0000-0001-6436-0863","observed_orcids":["https://orcid.org/0000-0001-6436-0863"]},"institutions":[{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J. Carrasco","raw_affiliation_strings":["Oncology, Grand Hopital de Charleroi Site Notre Dame, Charleroi, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Grand Hopital de Charleroi Site Notre Dame, Charleroi, Belgium","institution_ids":["https://openalex.org/I4210152698"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":{"value":5080,"currency":"USD","value_usd":5080},"fwci":0.0755,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.33269746,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"29","issue":null,"first_page":"viii89","last_page":"viii89"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1923999935388565,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.7950000166893005},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.8180000185966492},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9679999947547913},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7860000133514404},{"id":"https://openalex.org/keywords/tcr-repertoire","display_name":"T cell receptor repertoire","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.9159272313117981},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8670886754989624},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8503320217132568},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6507791876792908},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6216485500335693},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5250893831253052},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4676354229450226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45185011625289917},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4306367039680481},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.42874836921691895},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.4183223247528076},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4098953604698181},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.38122206926345825},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3216797113418579},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.14818641543388367}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdy271.274","doi":"https://doi.org/10.1093/annonc/mdy271.274","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy271.274","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdy271.274","doi":"https://doi.org/10.1093/annonc/mdy271.274","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy271.274","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4322769719","https://openalex.org/W4220927199","https://openalex.org/W4416786050","https://openalex.org/W3127886518","https://openalex.org/W3008580471","https://openalex.org/W4396587641","https://openalex.org/W2969017474","https://openalex.org/W7165852282","https://openalex.org/W2805345499","https://openalex.org/W4396587691"],"abstract_inverted_index":{"Background:":[0],"Most":[1],"patients":[2,222],"with":[3,13,121,170,256],"advanced":[4],"breast":[5],"cancer":[6],"(BC)":[7],"do":[8],"not":[9],"respond":[10],"to":[11,23,72,84,131,143,186,199,228],"immunotherapy":[12],"immunostimulating":[14],"antibodies.":[15],"Breast":[16],"tumours":[17,39],"are":[18],"considered":[19],"poorly":[20],"antigenic":[21],"due":[22],"a":[24,68,98,118,122,164,257,298],"low":[25],"mutational":[26],"load,":[27],"yet":[28],"they":[29],"contain":[30],"tumour-infiltrating":[31,264],"lymphocytes":[32],"(TILs).":[33],"As":[34],"continuous":[35],"immune":[36,42],"pressure":[37],"selects":[38],"that":[40,61],"escape":[41],"destruction,":[43],"there":[44],"is":[45,97,130,162,185],"growing":[46],"interest":[47],"for":[48,54,90,150,203,210,253,311],"the":[49,74,79,87,133,154,159,178,192,248,260,276,286,294,312],"use":[50],"of":[51,78,135,139,177,233,250,263,278,288,336],"immunostimulatory":[52],"antibodies":[53],"early-stage":[55],"cancers.":[56],"Based":[57],"on":[58,191,259,290],"data":[59],"suggesting":[60],"anthracyclines":[62],"increase":[63],"tumour":[64],"immunogenicity,":[65],"we":[66],"initiated":[67,169],"phase":[69,119,165,213],"Ib/II":[70],"trial":[71,101,301],"study":[73,96,113],"safety":[75,134],"and":[76,106,208,223,235,241,269,285],"efficacy":[77,189,255],"anti-PD-L1":[80,254],"antibody":[81],"durvalumab":[82,140,180,289],"combined":[83],"epirubicin":[85],"in":[86,153,175],"neoadjuvant":[88,155],"setting":[89],"localized":[91],"BC.":[92],"Trial":[93],"design:":[94],"B-IMMUNE":[95],"multicentric":[99],"prospective":[100],"including":[102],"luminal":[103,204,218],"B":[104,205,219],"HER2(-)":[105,206,220],"triple":[107],"negative":[108],"BC":[109,207,221],"(TNBC)":[110],"patients.":[111],"The":[112,212],"includes":[114],"two":[115],"parts.":[116],"First":[117],"Ib":[120],"3":[123,125],"+":[124],"design":[126],"whose":[127],"primary":[128,183],"objective":[129,184],"evaluate":[132,187,275],"an":[136,171],"increasing":[137],"number":[138],"infusions":[141],"associated":[142],"dose-dense":[144],"Epirubicin-Cyclophosphamide":[145],"(EC)":[146],"after":[147,270],"weekly":[148],"paclitaxel":[149],"12":[151],"weeks":[152],"setting.":[156],"Then,":[157],"if":[158],"durvalumab-EC":[160],"combination":[161],"safe,":[163],"II":[166,214],"will":[167,215,274],"be":[168],"open-label":[172],"4:1":[173],"randomization":[174],"favour":[176],"experimental":[179],"arm.":[181],"Its":[182],"clinical":[188],"based":[190],"complete":[193],"pathological":[194],"response":[195],"rate":[196,231],"(pCR)":[197],"compared":[198],"historical":[200],"controls":[201],"(15%":[202],"30%":[209],"TNBC).":[211],"include":[216,247],"24":[217],"22":[224],"TNBC":[225],"patients,":[226],"allowing":[227],"detect":[229],"pCR":[230],"improvements":[232],"40%":[234],"60%,":[236],"respectively":[237],"(\u03b1":[238],"\u2264":[239,243],"0.1":[240],"\u03b2":[242],"0.1).":[244],"Exploratory":[245],"objectives":[246],"identification":[249],"predictive":[251],"biomarkers":[252],"focus":[258],"TCR":[261],"repertoires":[262],"T":[265,281],"cells":[266,282],"collected":[267],"before":[268],"durvalumab.":[271],"Translational":[272],"research":[273],"presence":[277],"tumour-specific":[279],"CD8":[280],"among":[283],"TILs":[284],"influence":[287],"this":[291],"population":[292],"using":[293],"control":[295],"arm":[296],"as":[297],"reference.":[299],"Clinical":[300],"identification:":[302],"NTC03356860,":[303],"ONCOGHdC2015_01,":[304],"November":[305],"29,":[306],"2017.":[307],"Legal":[308],"entity":[309],"responsible":[310],"study:":[313],"Grand":[314],"H\u00f4pital":[315],"de":[316],"Charleroi":[317],"(GHdC).":[318],"Funding:":[319],"AstraZeneca,":[320],"T\u00e9l\u00e9vie":[321],"(FNRS).":[322],"Disclosure:":[323],"J.":[324],"Carrasco:":[325],"Research":[326],"grant:":[327],"AstraZeneca.":[328],"All":[329],"other":[330],"authors":[331],"have":[332],"declared":[333],"no":[334],"conflicts":[335],"interest.":[337]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-10-26T00:00:00"}